Stay updated on Intranasal Ketamine in Autism Social Impairment Clinical Trial
Sign up to get notified when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.

Latest updates to the Intranasal Ketamine in Autism Social Impairment Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a Locations section with Ohio as the study site. Removed the Ohio Locations and HHS Vulnerability Disclosure items; page revision updated to v3.3.3.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe government funding operating-status banner was removed from the page. Core study details, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check66 days agoChange DetectedThe screenshots indicate cosmetic layout and formatting updates to the Study Details page without changes to core trial data such as eligibility criteria, enrollment, locations, and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference5%

- Check102 days agoChange DetectedShift from superconducting drug/solution topics to chemical substances (chlorides, hydrochloric acid, chlorine compounds, inorganic and sodium salts) and a version upgrade to v3.1.0.SummaryDifference2%

Stay in the know with updates to Intranasal Ketamine in Autism Social Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.